A new study reports lower concentrations of α-synuclein in the cerebrospinal fluid of Parkinson's patients is associated with reduced cognitive performance.
According to researchers, a new antibody therapy can help treat TBI and prevent the associated development of Alzheimer's disease and CTE.
Researchers discover a potential genetic variant which could make the brain more resilient to Alzheimer's disease.
Researchers discover why aging and molecular changes in brain circuitry can lead to tangles associated with AD.
Researchers discover by looking at amyloid-beta and tau independently that the interaction between the proteins could be the key to the cognitive decline associated with Alzheimer's disease. As the interaction between the two proteins increased, the progression of Alzheimer's worsened.
